Table 2.
Distribution of Attributable Moderate-to-Severe Diarrhea Cases by Study Site, Age Group, and Sex in the Vaccine Impact on Diarrhea in Africa Study
| Subcategory | Adenovirus 40/41 | Astrovirus | Sapovirus | Rotavirus | |
|---|---|---|---|---|---|
| n = 127 | n = 141 | n = 90 | n = 609 | ||
| Site | The Gambia | 48 (37.8%) | 50 (35.5%) | 0 | 233 (38.3%) |
| Mali | 29 (22.8%) | 48 (34.0%) | 0 | 189 (31.0%) | |
| Kenya | 50 (39.4%) | 43 (30.5%) | 90 (100.0%) | 187 (30.7%) | |
| Age, mo | 0–11 | 72 (56.7%) | 36 (25.5%) | 24 (26.7%) | 259 (42.5%) |
| 12–23 | 43 (33.9%) | 84 (59.6%) | 38 (42.2%) | 235 (38.6%) | |
| 24–59 | 12 (9.4%) | 21 (14.9%) | 28 (31.1%) | 115 (18.9%) | |
| Median (Q1–Q3) | 11 (8–15.5) | 15 (11–20) | 16.5 (11–25.75) | 13 (9–20) | |
| Sex | Male | 64 (50.4%) | 75 (53.2%) | 52 (57.8%) | 324 (53.2%) |
| Female | 63 (49.6%) | 66 (46.8%) | 38 (42.2%) | 285 (46.8%) |